financetom
Business
financetom
/
Business
/
Cars.com Insider Bought Shares Worth $299,558, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cars.com Insider Bought Shares Worth $299,558, According to a Recent SEC Filing
May 26, 2025 6:04 AM

12:39 PM EDT, 05/12/2025 (MT Newswires) -- Thomas Alex Vetter, Director, CEO, on May 09, 2025, executed a purchase for 27,870 shares in Cars.com ( CARS ) for $299,558. Following the Form 4 filing with the SEC, Vetter has control over a total of 844,897 common shares of the company, with 844,897 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1683606/000095017025068872/xslF345X05/ownership.xml

Price: 10.90, Change: +0.47, Percent Change: +4.48

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Petrobras, Trade Group to Explore Energy Opportunities in Brazil
Petrobras, Trade Group to Explore Energy Opportunities in Brazil
Apr 29, 2024
02:52 PM EDT, 04/29/2024 (MT Newswires) -- Petrobras (PBR) said Monday it will work with a Brazilian trade group to identify new business opportunities in the natural gas and energy sector. The Brazilian state-owned petroleum company's so-called protocol of intent with the Brazilian Chemical Industry Association, or ABIQUIM, is valid for one year, with the possibility of an extension. ABIQUIM...
Immix Biopharma Gets Orphan Drug Label in Europe For Multiple Myeloma Treatment
Immix Biopharma Gets Orphan Drug Label in Europe For Multiple Myeloma Treatment
Apr 29, 2024
02:50 PM EDT, 04/29/2024 (MT Newswires) -- Immix Biopharma ( IMMX ) said Monday that the European Commission has granted orphan drug designation to NXC-201 for the treatment of multiple myeloma. The designation qualifies NXC-201 among others for 10 years of market exclusivity once authorized in the EU and access to the EU centralized authorization procedure, the company said. The...
Raymond James Financial Insider Sold Shares Worth $505,107, According to a Recent SEC Filing
Raymond James Financial Insider Sold Shares Worth $505,107, According to a Recent SEC Filing
Apr 29, 2024
02:52 PM EDT, 04/29/2024 (MT Newswires) -- Steven M Raney, President & CEO, RJBank, on April 26, 2024, sold 4,174 shares in Raymond James Financial ( RJF ) for $505,107. Following the Form 4 filing with the SEC, Raney has control over a total of 54,035 shares of the company, with 51,009 shares held directly and 3,026 controlled indirectly. SEC...
Top Midday Gainers
Top Midday Gainers
Apr 29, 2024
02:36 PM EDT, 04/29/2024 (MT Newswires) -- Deciphera Pharmaceuticals ( DCPH ) said Monday that it agreed to be acquired by Japan-based ONO Pharmaceutical through a tender offer in a deal worth roughly $2.4 billion. Shares of Deciphera soared 72% as intraday trading volume soared to over 43.4 million from a daily average of about 515,000. Mullen Automotive ( MULN...
Copyright 2023-2026 - www.financetom.com All Rights Reserved